Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA

Virus Research

Volumn 167, Issue 1, 2012, Pages 74-85

  Sejima, Hiroe ^a   Mori, Kyoko ^a   Ariumi, Yasuo ^a,b   Ikeda, Masanori ^a   Kato, Nobuyuki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

ACSM3; ALXR; ANGPT1; ANXA1; AREG; BASP1; CDKN2C; CIDEC; CPB2; Downregulated host genes; E1; EGF; HCC; HCV; HCV RNA replication system; HSPA6; ICAM 1; IFN; Li23 cells; Long term RNA replication; PI3; PLA1A; RT PCR; SEL1L3; SLC1A3; SLC39A4; TBC1D4; THSD4; Upregulated host genes; WISP3

Indexed keywords

GAMMA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS GENE; VIRUS REPLICATION;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, VIRAL; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84861480601     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.04.008     Document Type: Article

References (51)

1. Abe K., Ikeda M., Dansako H., Naka K., Kato N. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. Virus Research 2007, 125:88-97.
2. Ang E.Z.-F., Nguyen H.T., Sim H.-L., Putti T.C., Lim L.H. Annexin-1 regulates growth arrest induced by high levels of estrogen in MCF-7 breast cancer cells. Molecular Cancer Research 2009, 7:266-274.
3. Bartenschlager R. The hepatitis C virus replicon system: from basic research to clinical application. Journal of Hepatology 2005, 43:210-216.
4. Bartenschlager R., Sparacio S. Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture. Virus Research 2007, 127:195-207.
5. Carpenter B., Hill K.J., Charalambous M., Wagner K.J., Lahiri D., James D.I., Andersen J.S., Schumacher V., Royer-Pokora B., Mann M., Ward A., Roberts S.G.E. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Molecular and Cell Biology 2004, 24:537-549.
6. Choo Q., Kuo G., Weiner A., Overby L., Bradley D., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
7. Dansako H., Naganuma A., Nakamura T., Ikeda F., Nozaki A., Kato N. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Research 2003, 97:17-30.
8. Fong Y.-C., Lin C.-Y., Su Y.-C., Chen W.-C., Tsai F.-J., Tsai C.-H., Huang C.-Y., Tang C.-H. CCN6 enhances ICAM-1 expression and cell motility in human chondrosarcoma cells. Journal of Cellular Physiology 2012, 227:223-232.
9. Garcia Pedrero J.M., Fernandez M.P., Morgan R.O., Herrero Zapatero A., Gonzalez M.V., Suarez Nieto C., Rodrigo J.P. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. American Journal of Pathology 2004, 164:73-79.
10. Hartl M., Nist A., Khan M.I., Valovka T., Bister K. Inhibition of Myc-induced cell transformation by brain acid-soluble protein 1 (BASP1). Proceedings of the National Academy of Sciences of the United States of America 2009, 106:5604-5609.
11. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:5547-5551.
12. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi T., Kato N., Kimura K., Shimotohno K. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:10773-10777.
13. Hillebrandt S., Wasmuth H.E., Weiskirchen R., Hellerbrand C., Keppeler H., Werth A., Schirin-Sokhan R., Wilkens G., Geier A., Lorenzen J., Koehl J., Gressner A.M., Matern S., Lammert F. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nature Genetics 2005, 37:835-843.
14. Hu N., Flaig M.J., Su H., Shou J.-Z., Roth M.J., Li W.-J., Wang C., Goldstein A.M., Li G., Emmert-Buck M.R., Taylor P.R. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clinical Cancer Research 2004, 10:6013-6022.
15. Huang W., Gonzalez M.E., Toy K.A., Banerjee M., Kleer C.G. Blockade of ccn6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells. Cancer Research 2010, 70(8):3340-3350.
16. Huang W., Zhang Y., Varambally S., Chinnaiyan A.M., Banerjee M., Merajver S.D., Kleer C.G. Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1. American Journal of Pathology 2008, 172(4):893-904.
17. Huang W.-C., Chan S.-T., Yang T.-L., Tzeng C.-C., Chen C.-C. Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel alpha-methylene-butyrolactone derivatives. Carcinogenesis 2004, 25:1925-1934.
18. Ikeda M., Abe K., Dansako H., Nakamura T., Naka K., Kato N. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochemical and Biophysical Research Communications 2005, 329:1350-1359.
19. Ikeda M., Sugiyama K., Mizutani T., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., Kato N. Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Research 1998, 56:157-167.
20. Ikeda M., Yi M., Li K., Lemon S.M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. Journal of Virology 2002, 76:2997-3006.
21. Kane S., Sano H., Liu S.C.H., Asara J.M., Lane W.S., Garner C.C., Lienhard G.E. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. Journal of Biological Chemistry 2002, 277:22115-22118.
22. Kato N., Abe K., Mori K., Ariumi Y., Dansako H., Ikeda M. Genetic variability and diversity of intracellular genome-length hepatitis C virus RNA in long-term cell culture. Archives of Virology 2009, 154:77-85.
23. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:9524-9528.
24. Kato N., Mori K., Abe K., Dansako H., Kuroki M., Ariumi Y., Wakita T., Ikeda M. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line. Virus Research 2009, 146:41-50.
25. Kato N., Sugiyama K., Namba K., Dansako H., Nakamura T., Takami M., Naka K., Nozaki A., Shimotohno K. Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochemical and Biophysical Research Communications 2003, 306:756-766.
26. Krieger N., Lohmann V., Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. Journal of Virology 2001, 75:4614-4624.
27. Lindenbach B.D., Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 2005, 436:933-938.
28. Lohmann V., Korner F., Koch J.-O., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285:110-113.
29. Mîinea C.P., Sano H., Kane S., Sano E., Fukuda M., Peränen J., Lane W.S., Lienhard G.E. As160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochemical Journal 2005, 391:87-93.
30. Mori K., Abe K., Dansako H., Ariumi Y., Ikeda M., Kato N. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis c. Biochemical and Biophysical Research Communications 2008, 371:104-109.
31. Mori K., Ikeda M., Ariumi Y., Dansako H., Wakita T., Kato N. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system. Virus Research 2011, 157:61-70.
32. Mori K., Ikeda M., Ariumi Y., Kato N. Gene expression profile of Li23, a new human hepatoma cell line that enables robust hepatitis C virus replication: comparison with HuH-7 and other hepatic cell lines. Hepatology Research 2010, 40:1248-1253.
33. Moribe T., Iizuka N., Miura T., Stark M., Tamatsukuri S., Ishitsuka H., Hamamoto Y., Sakamoto K., Tamesa T., Oka M. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. International Journal of Oncology 2008, 33:949-958.
34. Mosevitsky M.I., Capony J.P., Skladchikova G.Y., Novitskaya V.A., Plekhanov A.Y., Zakharov V.V. The BASP1 family of myristoylated proteins abundant in axonal termini. Primary structure analysis and physico-chemical properties. Biochimie 1997, 79:373-384.
35. Myles T., Nishimura T., Yun T.H., Nagashima M., Morser J., Patterson A.J., Pearl R.G., Leung L.L.K. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. Journal of Biological Chemistry 2003, 278:51059-51067.
36. Naka K., Dansako H., Kobayashi N., Ikeda M., Kato N. Hepatitis C virus NS5B delays cell cycle progression by inducing interferon- via toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 2006, 346:348-362.
37. Pennica D., Swanson T.A., Welsh J.W., Roy M.A., Lawrence D.A., Lee J., Brush J., Taneyhill L.A., Deuel B., Lew M., Watanabe C., Cohen R.L., Melhem M.F., Finley G.G., Quirke P., Goddard A.D., Hillan K.J., Gurney A.L., Botstein D., Levine A.J. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:14717-14722.
38. Perretti M., D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nature Reviews Immunology 2009, 9:62-70.
39. Redlitz A., Tan A.K., Eaton D.L., Plow E.F. Plasma carboxypeptidases as regulators of the plasminogen system. Journal of Clinical Investigation 1995, 96:2534-2538.
40. Rowland A.F., Fazakerley D.J., James D.E. Mapping insulin/GLUT4 circuitry. Traffic 2011, 12:672-681.
41. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y., Choo Q., Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:6547-6549.
42. Sharif S.A., Du X., Myles T., Song J.J., Price E., Lee D.M., Goodman S.B., Nagashima M., Morser J., Robinson W.H., Leung L.L.K. Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis and Rheumatism 2009, 60:2902-2912.
43. Song J.J., Hwang I., Cho K.H., Garcia M.A., Kim A.J., Wang T.H., Lindstrom T.M., Lee A.T., Nishimura T., Zhao L., Morser J., Nesheim M., Goodman S.B., Lee D.M., Bridges S.L., Gregersen P.K., Leung L.L., Robinson W.H. Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis. Journal of Clinical Investigation 2011, 121:3517-3527.
44. Thomas D. Hepatitis C epidemiology. Current Topics in Microbiology and Immunology 2000, 242:25-41.
45. Thorstensen L., Diep C.B., Meling G.I., Aagesen T.H., Ahrens C.H., Rognum T.O., Lothe R.A. Wnt1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology 2001, 121:1275-1280.
46. Tsunedomi R., Ogawa Y., Iizuka N., Sakamoto K., Tamesa T., Moribe T., Oka M. The assessment of methylated BAPS1 and SRD5A2 levels in the detection of early hepatocellular carcinoma. International Journal of Oncology 2010, 36:205-212.
47. Ueda Y., Mori K., Ariumi Y., Ikeda M., Kato N. Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents. Biochemical and Biophysical Research Communications 2011, 409:663-668.
48. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.-G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine 2005, 11:791-796.
49. Xin W., Rhodes D.R., Ingold C., Chinnaiyan A.M., Rubin M.A. Dysregulation of the annexin family protein family is associated with prostate cancer progression. American Journal of Pathology 2003, 162:255-261.
50. Yazid S., Ayoub S.S., Solito E., McArthur S., Vo P., Dufton N., Flower R.J. Anti-allergic drugs and the annexin-A1 system. Pharmacological Report 2010, 62:511-517.
51. Zhang Z., Huang L., Zhao W., Rigas B. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Research 2010, 70:2379-2388.